Related Experiment Videos
Interaction Between Mevalonate Pathway and Retinoic Acid-Induced Differentiation
Journal of Biomedicine & Biotechnology
|December 19, 2002
Summary
Compactin enhances all-trans retinoic acid (ATRA)-induced HL-60 cell differentiation by modulating HMG-CoA reductase activity. Farnesyltransferase inhibitors abolished ATRA differentiation, indicating farnesylated proteins are crucial.
Area of Science:
- Cell biology
- Biochemistry
- Molecular biology
Background:
- All-trans retinoic acid (ATRA) is a known inducer of differentiation in the HL-60 cell line.
- Compactin, an inhibitor of 3-hydroxy-3-methylglutaryl (HMG) CoA reductase, enhances ATRA-induced differentiation.
Purpose of the Study:
- To investigate the role of sterol and nonsterol isoprenoid biosynthesis pathways in ATRA-induced HL-60 cell differentiation.
- To elucidate the specific mechanisms by which compactin enhances ATRA-induced differentiation.
Main Methods:
- HL-60 cells were pretreated with compactin, followed by ATRA treatment.
- Cholesterol levels were manipulated using low-density lipoprotein (LDL).
- Inhibitors of geranylgeranyltransferase (GGTI-298) and farnesyltransferase (FTI-II, FTI-277) were used to assess pathway involvement.
Main Results:
- Compactin pretreatment significantly increased ATRA-induced cell differentiation from 34.9% to 73%.
- Excess cholesterol reduced ATRA-induced differentiation and cell growth.
- Farnesyltransferase inhibitors completely abolished ATRA-induced differentiation, while geranylgeranyltransferase inhibitors had no effect.
Conclusions:
- The study confirms the involvement of farnesylated proteins in the ATRA-induced differentiation mechanism of HL-60 cells.
- Modulation of HMG-CoA reductase activity and subsequent isoprenoid biosynthesis plays a critical role in this process.